LyondellBasell Industries N.V. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LyondellBasell Industries N.V. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	29,183	34,484	39,004	34,727	27,753	46,173	50,451	33,336	33,394	30,153
Cost of revenue	23,191	28,059	32,529	29,301	24,359	37,397	43,847	28,435	28,750	27,576
Gross profit	5,992	6,425	6,475	5,426	3,394	8,776	6,604	4,901	4,644	2,577
Research and development	99	106	115	111	113	124	124	130	135	136
Selling, general and administrative	833	859	1,129	1,199	1,140	1,255	1,310	1,539	1,642	1,610
Operating income	5,060	5,460	5,231	4,116	1,559	6,773	5,101	2,725	1,918	-420
Interest expense	322	491	360	347	526	519	287	477	481	487
Interest income	17	24	45	19	12	9	29	129	150	97
Other non-operating income	111	179	106	39	85	62	-72	-58	47	113
Pre-tax income	5,233	5,493	5,311	4,052	1,386	6,786	4,776	2,299	1,701	-715
Income tax	1,386	598	613	648	-43	1,163	882	433	259	70
Net income to minority interests	1	-2	0	0
Net income	3,836	4,879	4,690	3,397	1,427	5,617	3,889	2,121	1,367	-738
EBITDA	6,124	6,634	6,472	5,428	2,944	8,166	6,368	4,259	3,440	970
EPS, basic	9.15	12.23	12.04	9.59	4.24	16.77	11.84	6.48	4.16	-2.34
EPS, diluted	9.13	12.23	12.01	9.58	4.24	16.75	11.81	6.46	4.15	-2.34
Dividend per share	3.33	3.55	4.00	4.15	4.20	4.44	4.70	4.94	5.27	5.45

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	875	1,523	332	858	1,763	1,472	2,151	3,390	3,375	3,443
Short-term investments	1,147	1,307	892	196	702	9	0	2,432	2,610	2,030
Receivables	2,716	3,359	3,355	2,981	3,291	4,565	3,392
Inventory	3,809	4,217	4,515	4,588	4,344	4,901	4,804	4,765	4,658	3,533
Other current assets	923	1,147	1,255	736	1,382	1,022	1,292	1,475	928	612
Total current assets	9,599	11,738	10,566	9,510	11,634	12,217	11,845	13,152	12,266	10,868
Property, plant and equipment	10,137	10,997	12,477	14,130	14,386	14,556	15,387	15,547	15,066	15,833
Lease right-of-use assets				1,468	1,492	1,946	1,725	1,529	1,467	1,514
Goodwill	528	570	1,814	1,891	1,953	1,875	1,827	1,647	1,561	708
Intangible assets	550	568	965	869	751	695	662	641	577	450
Other non-current assets	618	261	353	461	458	667	624	577	688	667
Total assets	23,442	26,206	28,278	30,435	35,403	36,742	36,365	37,000	35,746	34,003
Accounts payable	2,028	2,258	2,560	2,516	2,398	3,460	3,106
Accrued liabilities	1,415	1,812	1,536	1,822	1,883	2,571	2,396	2,436	2,356	1,956
Deferred revenue	22	61	128	103	157	169	167	175	110	113
Short-term debt	2	2	5	3	8	6	432	782	498	588
Total current liabilities	4,540	4,777	5,513	5,198	5,502	7,230	6,760	7,150	6,705	6,129
Long-term debt	8,385	8,549	8,497	11,614	15,286	11,246	10,540	10,333	10,532	12,124
Lease liabilities				1,216	1,222	1,649	1,510	1,409	1,419	1,327
Other non-current liabilities	2,113	2,275	1,897	2,213	2,957	2,295	1,954	2,164	1,967	1,900
Total liabilities	17,369	17,256	17,998	22,372	27,415	24,870	23,736	24,056	23,272	23,910
Total debt	8,387	8,551	8,502	11,617	15,294	11,252	10,972	11,115	11,030	12,712
Paid-in capital	10,191	10,206	7,041	5,954	5,986	6,044	6,119	6,145	6,150	6,148
Retained earnings	12,282	15,746	6,763	4,435	4,440	8,563	9,195	9,692	9,325	6,812
Treasury stock	-14,945	-15,749	-2,206	-580	-531	-965	-1,346	-1,450	-1,500	-1,587
Other comprehensive income	-1,511	-1,285	-1,363	-1,784	-1,943	-1,803	-1,372	-1,476	-1,532	-1,310
Shareholders' equity	6,048	8,949	10,257	8,044	7,971	11,858	12,615	12,930	12,462	10,082
Minority interests	25	1	23	19	17	14	14	14	12	11
Total equity	6,073	8,950	10,280	8,063	7,988	11,872	12,629	12,944	12,474	10,093
Total liabilities and equity	23,442	26,206	28,278	30,435	35,403	36,742	36,365	37,000	35,746	34,003
Shares outstanding	404	395	376	333	334	330	326	324	324	322

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	3,837	4,877	4,690	3,397	1,427	5,617	3,889	2,121	1,367	-738
Depreciation and amortization	1,064	1,174	1,241	1,312	1,385	1,393	1,267	1,534	1,522	1,390
Stock-based compensation	38	55	39	48	55	66	70	91	91	91
Deferred income tax	357	-587	260	209	331	-198	369	132	-406	-184
Change in receivables	-383	-521	433	367	-246	-1,519	1,005	110	127	687
Change in inventory	123	-237	-141	-129	340	-742	-91	18	25	945
Change in payables	383	165	-199	-251	217	1,301	-464	141	-122	-768
Cash from operations	5,606	5,206	5,471	4,961	3,404	7,695	6,119	4,942	3,819	2,262
Capital expenditures	-2,243	-1,547	-2,105	-2,694	-1,947	-1,959	-1,890	-1,531	-1,839	-1,878
Acquisitions	0	0	-1,776	0	0
Purchases of investments				-108	-270	0	0
Sales and maturities of investments	674	499	423	331	24	346
Cash from investing	-2,301	-1,756	-3,559	-1,635	-4,906	-1,502	-1,977	-1,777	-1,853	-1,776
Debt issued	812	990	0	5,031	6,378	0	0	500	744	1,990
Debt repaid	0	-1,000	-394	-2,974	-2,880	-3,925	0	-425	-776	-492
Share buybacks	-2,938	-866	-1,854	-3,752	-4	-463	-420	-211	-195	-201
Dividends paid	-1,395	-1,415	-1,554	-1,462	-1,405	-1,486	-3,246	-1,610	-1,720	-1,764
Cash from financing	-3,349	-2,859	-3,008	-2,835	2,271	-6,385	-3,407	-1,950	-1,895	-507
Exchange rate effect	-9	59	-31	-4	108	-96	-56
Net change in cash	-53	650	-1,127	487	877	-288	679	1,249	-17	61
Free cash flow	3,363	3,659	3,366	2,267	1,457	5,736	4,229	3,411	1,980	384
Interest paid	313	333	333	318	498	414	297	487	503	483
Income taxes paid	741	1,044	1,209	403	176	310	746	465	343	393

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $58.14 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	12.8%	Gross profit / revenue.
Operating margin	3.1%	Operating income / revenue.
EBITDA margin	7.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-0.2%	Pre-tax income / revenue.
Net margin	-1.1%	Net income / revenue.
FCF margin	5.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	9.5%	Cash from operations / revenue.
Return on equity (ROE)	-3.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-1.0%	Net income / average total assets.
Return on invested capital (ROIC)	3.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	0.4%	Research and development expense / revenue.
SG&A / revenue	5.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.5%	Capital expenditures / revenue.
D&A / revenue	4.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-9.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-15.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-44.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-26.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-5.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-121.9%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-71.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-46.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-19.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-154.0%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-156.4%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-40.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-28.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-7.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-80.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-55.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-23.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	3.4%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	5.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	5.3%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-19.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-7.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-4.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-2.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-0.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.64x	Current assets / current liabilities.
Quick ratio	0.57x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.57x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.19x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	36.8%	Total debt / total assets.
Liabilities / assets	69.0%	Total liabilities / total assets.
Net debt	$8.61B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.61x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	1.79x	Operating income / interest expense.
Working capital	$4.56B	Current assets - current liabilities.
Goodwill and intangibles / assets	3.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$9.57B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.90x	Revenue / average total assets.
Fixed asset turnover	1.99x	Revenue / average property, plant and equipment.
Inventory turnover	6.67x	Cost of revenue / average inventory.
Days inventory	55 days	365 x average inventory / cost of revenue.
Capex / operating cash flow	46.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
Book value per share	$33.04	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$29.63	Tangible book value / shares outstanding.
Cash per share	$12.58	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	84.5%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	0.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$18.78B	Share price x shares outstanding.
Enterprise value	$27.39B	Market cap + total debt - cash - short-term investments.
P/S	0.60x	Market cap / revenue.
P/B	1.76x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.96x	Market cap / tangible book value, when positive.
P/FCF	11.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.32x	Market cap / cash from operations, when positive.
EV/Sales	0.88x	Enterprise value / revenue.
EV/EBIT	28.4x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	17.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	8.4%	Free cash flow / market cap.
Earnings yield	-1.8%	Net income / market cap (the inverse of P/E).
Dividend yield	7.1%	Dividends paid over the period / market cap.
Shareholder yield	7.1%	(Dividends paid + share buybacks) / market cap.

What was LyondellBasell Industries N.V.'s revenue in fiscal 2025?

LyondellBasell Industries N.V. reported revenue of $30.15B for fiscal 2025, 9.7% lower than the year before.

Was LyondellBasell Industries N.V. profitable in fiscal 2025?

No. It reported a net loss of $738.0M.

How much free cash flow did LyondellBasell Industries N.V. generate in fiscal 2025?

Cash from operations of $2.26B minus capital expenditures of $1.88B left free cash flow of $384.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LyondellBasell Industries N.V.